Table 3.
Indication | Appropriateness criteria (median score) | Note | |
---|---|---|---|
Asymptomatic (use of coronary MRA) | |||
13 | Low CHD risk (Framingham) | I (3) | Highly agreed |
14 | Moderate CHD risk (Framingham) | I (3) | |
15 | High CHD risk (Framingham) | U (5) |
Indication | Appropriateness criteria (median score) | Note | |
---|---|---|---|
Asymptomatic (use of coronary MRA) | |||
13 | Low CHD risk (Framingham) | I (3) | Highly agreed |
14 | Moderate CHD risk (Framingham) | I (3) | |
15 | High CHD risk (Framingham) | U (5) |